CARROLLTON, KY (October 01, 2017) – PMC Organometallix, Inc., a wholly owned subsidiary of PMC Group, has expanded its distribution agreement with Safic-Alcan to include Eastern Europe providing customers with sales, order fulfillment, and technical support. Effective immediately, Safic-Alcan will serve as an authorized distributor of PMC Organometallix’ s FASCAT® catalysts and Fine Chemicals—highly selective catalysts

MEMPHIS, TN (May 9, 2017) – PMC Biogenix, Inc., a wholly owned subsidiary of PMC Group, as part of its continuing effort to strengthen and build upon customer relationships, has initiated a comprehensive review of its go to market strategy. As part of this process, PMC Biogenix is consolidating certain historical product distribution channels in

MEMPHIS, TN (February 27, 2017) – PMC Biogenix, a wholly owned subsidiary of PMC Group, announced today that it has significantly expanded its production capacity for long chain fatty acid intermediates in Memphis, TN to support its recent expansions in fatty amide slip agent production. The Memphis expansion project will increase its capacity for erucic

MEMPHIS, TN (January 5, 2016) – PMC Biogenix, a wholly owned subsidiary of PMC Group, announced plans to invest in the expansion of its manufacturing capacity for fatty amide slip agents at its production facility in Gyeongju, South Korea. The project will increase PMC’s manufacturing capacity at the site by 30% and will be operational